The Repatriation General Hospital at Daw Park, South Australia, also commonly referred to as "The Repat" or just "Repat", was one of a number of Repatriation General Hospitals set up by the Commonwealth Government around the time of World War II to cater for returned serviceman.

During the past decade, Repatriation General Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 8 clinical trials were completed, i.e. on average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Repatriation General Hospital" #1 sponsor was "Abbott" with 2 trials, followed by "Amgen" with 2 trials sponsored, "Galapagos NV" with 2 trials sponsored, "Gilead Sciences" with 2 trials sponsored and "AstraZeneca" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Repatriation General Hospital" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "Flinders Medical Centre" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator, "Royal Adelaide Hospital" with 1 trials as a collaborator and "The Queen Elizabeth Hospital" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Repatriation General Hospital" are "Bronchiectasis" (3 trials), "Prostate Cancer" (2 trials), "Psoriatic Arthritis" (2 trials), "Rheumatoid Arthritis" (2 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Repatriation General Hospital" in a lesser frequency.

Most popular intervention types in "Repatriation General Hospital" are "Drug" (14 trials), "Biological" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "AZLI" (2 trials), "Apremilast 20mg" (2 trials), "Apremilast 30mg" (2 trials) and "Atrasentan" (2 trials). Other intervention names were less common.

The vast majority of trials in "Repatriation General Hospital" are 12 trials for "All" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Repatriation General Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Repatriation General Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Repatriation General Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".